Biostar Pharmaceuticals Probability of Future Pink Sheet Price Finishing Over 0.0099
| BSPMDelisted Stock | USD 0.01 0.00 0.00% |
Biostar |
Biostar Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biostar Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biostar Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biostar Pharmaceuticals is not yet fully synchronised with the market data | |
| Biostar Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Biostar Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Biostar Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Biostar Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biostar Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biostar to invest in growth at high rates of return. When we think about Biostar Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Biostar Pharmaceuticals reported the previous year's revenue of 317.79 K. Net Loss for the year was (5.7 M) with profit before overhead, payroll, taxes, and interest of 915.17 K. |
Biostar Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biostar Pink Sheet often depends not only on the future outlook of the current and potential Biostar Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biostar Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.3 M | |
| Short Long Term Debt | 2.3 M |
Biostar Pharmaceuticals Technical Analysis
Biostar Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Biostar Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biostar Pharmaceuticals. In general, you should focus on analyzing Biostar Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Biostar Pharmaceuticals Predictive Forecast Models
Biostar Pharmaceuticals' time-series forecasting models is one of many Biostar Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biostar Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Biostar Pharmaceuticals
Checking the ongoing alerts about Biostar Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biostar Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biostar Pharmaceuticals is not yet fully synchronised with the market data | |
| Biostar Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Biostar Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Biostar Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Biostar Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biostar Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biostar to invest in growth at high rates of return. When we think about Biostar Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Biostar Pharmaceuticals reported the previous year's revenue of 317.79 K. Net Loss for the year was (5.7 M) with profit before overhead, payroll, taxes, and interest of 915.17 K. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |